Fulcrum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.
CEOAlexander C. Sapir
CEOAlexander C. Sapir
Employees45
Employees45
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees45
Employees45
FULC Key Statistics
Market cap677.51M
Market cap677.51M
Price-Earnings ratio-8.69
Price-Earnings ratio-8.69
Dividend yield—
Dividend yield—
Average volume846.90K
Average volume846.90K
High today$10.48
High today$10.48
Low today$9.42
Low today$9.42
Open price$9.42
Open price$9.42
Volume839.97K
Volume839.97K
52 Week high$15.74
52 Week high$15.74
52 Week low$2.32
52 Week low$2.32
Stock Snapshot
Fulcrum Therapeutics(FULC) stock is priced at $10.17, giving the company a market capitalization of 677.51M. It carries a P/E multiple of -8.69.
During the trading session on 2026-01-13, Fulcrum Therapeutics(FULC) shares reached a daily high of $10.48 and a low of $9.42. At a current price of $10.17, the stock is +8.0% higher than the low and still -3.0% under the high.
Trading volume for Fulcrum Therapeutics(FULC) stock has reached 839.97K, versus its average volume of 846.9K.
The stock's 52-week range extends from a low of $2.32 to a high of $15.74.
The stock's 52-week range extends from a low of $2.32 to a high of $15.74.
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
10%
Sell
10%
People also own
Based on the portfolios of people who own FULC. This list is generated using Robinhood data, and it’s not a recommendation.